On BBC Breakfast yesterday the Prime Minister said that the jabs “will be very helpful to people who want to lose weight, ...

In an email to trust leaders today NHS England chief executive Amanda Pritchard stressed the need to transform the way ...

For adolescents with obesity, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is associated with a reduc ...

The Government is considering using drugs to help get obese people back to work - but they can lead to serious health ...

SGLT-2 inhibitors were associated with the lowest risk for incidental dementia relative to DPP-4 inhibitors and GLP-1RAs in type 2 diabetes.

DEMAND for fat jabs could overwhelm the NHS, the head of the health service has warned as Sir Keir Starmer piled hopes on using them to get obese jobseekers back to work. Amanda Pritchard, CEO of ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A new study found that obese teens prescribed with weight loss drugs are less likely to have suicidal thoughts.

A study by Health Innovation Manchester and Lilly will examine the “real-world effectiveness” of anti-obesity treatment Mounjaro, also known as tirzepatide, on weight loss, diabetes prevention, the ...

Mounjaro, which is made by Eli Lilly, is a glucagon-like peptide-1 (GLP-1) agonist, a family of medications that help manage ...

Researchers reveal the importance of personalized communication and side effect management in improving outcomes for patients ...

Researchers find that Semaglutide improves cognitive function and reduces amyloid and tau pathology in Alzheimer's disease ...